Macroscopic determination of the pre-burning condition of human remains recovered from an unusual forensic context: A case report

Understanding the taphonomic process of burning allows forensic practitioners to better interpret remains and reconstruct the burning incident in a medicolegal investigation. This can yield critical information, especially when other details, such as the biological profile, are obscured by fire. A forensic case involving human remains recovered within a Greek Orthodox cemetery that exhibited a distinctive pattern of differential burning is reported. The bones exhibited a range of differential burning in a pattern inconsistent with the anatomical position of the remains during heat exposure. No macroscopic signs of skeletal trauma or evidence of dismemberment were present on the remains. The pre-burning condition of the bones was inferred based on the presence of the differential burning and its localization identified through analysis of a suite of macroscopic heat-induced traits, as well as consideration of the forensic context. The anthropologists concluded that the bones were skeletonized prior to burning and that the remains were once interred or stored in an ossuary and were likely burned in a ritualistic manner, given the artifacts present and the conspicuous location of the burn area. This case highlights the practical experience required of forensic practitioners encountering burned remains and the necessity of understanding fire as a taphonomic agent that can be analyzed to determine pre-burning condition and the scenario of the burning event in a medicolegal investigation. Furthermore, this case underscores the achievability of pre-burning condition determination using macroscopic traits alone, even when there is a paucity of skeletal elements in the inventory. Due to knowledge of the funerary customs of modern-day Greece, the practitioners were able to interpret the origin of the remains, thereby this paper provides insight into a geographically specific forensic context. © 2021 Elsevier Ltd and Faculty of Forensic and Legal Medicin

Sexing the sternal rib end in modern Greeks: A virtual osteometric approach using high-resolution 3D surface models

Sex determination is one of the first biological attribute to be assessed when unidentified remains surface. In material of forensic interest, being able to use every skeletal element available for identification purposes is of paramount importance. The osteometric method from the sternal rib end has been found to generate accurate sex estimates, but as vari-ous studies have proved, all osteometric methods should be population-specific, as one equation does not fit all. The aim of this study is to assess sexual dimorphism in a contemporary Greek population sample of 68 males and 43 females, with the use of discriminant function analysis. The superior-inferior height (SIH) and anterior-posterior breadth (APB) from the third to fifth sternal rib ends of both sides were taken from 3D models created with the use of a hand-held 3D scanner. The results demonstrated that SIH is more sexually dimorphic than APB (alpha value of .05) while the application of İşcan’s (1985) formula on the contemporary Greek sample, provided results of low accuracy, ranging from 48.6–52.4%. The cross-validated discriminant functions equations for the current sample, produced results ranging between 74.0–82.9% indicating that population-specific formulas produce results of higher accuracy, that are vital in cases of forensic interest. © 2022 The Authors

Supporting service differentiation in wireless sensor networks

The evolution of wireless sensor technology allows for the provision of enhanced services to miscellaneous application domains. In parallel, Quality of Service (QoS) support becomes necessary to satisfy the needs of these new service models. This paper presents QoS requirements from a service model perspective and describes challenges for QoS support in WSNs. We also provide a review of current efforts in Medium Access Control (MAC) QoS support in WSNs. Then, we investigate various performance metrics of IEEE 802.15.4 standard in order to determine the technological issues that arise. From the outcome of the experiments conducted, using ns-2, we identified that different schemes of services and application scenarios for different ways of deployment, scales of network and traffic load can satisfy diverse user needs and requirements. © 2011 IEEE

Autoimmunity to neuronal nicotinic acetylcholine receptors

Nicotinic acetylcholine receptors (nAChRs) are widely expressed in many and diverse cell types, participating in various functions of cells, tissues and systems. In this review, we focus on the autoimmunity against neuronal nAChRs, the specific autoantibodies and their mechanisms of pathological action in selected autoimmune diseases. We summarize the current relevant knowledge from human diseases as well as from experimental models of autoimmune neurological disorders related to antibodies against neuronal nAChR subunits. Despite the well-studied high immunogenicity of the muscle nAChRs where autoantibodies are the main pathogen of myasthenia gravis, autoimmunity to neuronal nAChRs seems infrequent, except for the autoantibodies to the ganglionic receptor, the α3 subunit containing nAChR (α3-nAChR), which are detected and are likely pathogenic in Autoimmune Autonomic Ganglionopathy (AAG). We describe the detection, presence and function of these antibodies and especially the recent development of a cell-based assay (CBA) which, contrary to until recently available assays, is highly specific for AAG. Rare reports of autoantibodies to the other neuronal nAChR subtypes include a few cases of antibodies to α7 and/or α4β2 nAChRs in Rasmussen encephalitis, schizophrenia, autoimmune meningoencephalomyelitis, and in some myasthenia gravis patients with concurrent CNS symptoms. Neuronal-type nAChRs are also present in several non-excitable tissues, however the presence and possible role of antibodies against them needs further verification. It is likely that the future development of more sensitive and disease-specific assays would reveal that neuronal nAChR autoantibodies are much more frequent and may explain the mechanisms of some seronegative autoimmune diseases. © 2023 The Author

Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis

In autoimmune myasthenia gravis (MG), the identification of antibodies and characterization of serological subgroups is of great importance for diagnosis and management of the disease. Our aims were to study the frequency of antibodies against lipoprotein-related protein 4 (LRP4), agrin, and titin using the most recent techniques, and to characterize corresponding clinical features and autoimmune diseases (AID) in 100 MG-patients. The antibody frequencies in the 55 AChR-antibody positive patients were 7% LRP4, 5% agrin, 53% titin, and in the 45 AChR-antibody negative patients 2% MuSK, 2% LRP4, 2% agrin, and 27% titin. LRP4-MG presented late-onset age, mild symptoms, good therapeutic response, and no thymic changes. Agrin-MG showed early onset age, mild-to-severe symptoms, and moderate treatment response. The phenotype of titin-MG depended on AChR-antibodies: AChR-antibody negative patients presented with mostly mild limb muscle weakness, whereas AChR-antibody positive patients showed more frequently severe symptoms, including myasthenic crisis, bulbar predominance, and thymoma. Additional AID were detected in 32% of MG-patients, most frequently Hashimoto's thyroiditis (21%). Based on our data, we recommend the detection of LRP4-antibodies for at least AChR-antibody negative MG-patients and titin-antibodies for all MG-patients. We propose taking an accurate medical history for typical symptoms of Hashimoto's thyroiditis in MG-patients.status: publishe

MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: A case for expanding anti-MOG testing?

MOG-antibody associated demyelinating disease is a new emerging diagnostic entity. Recently, international recommendations for testing of anti-MOG antibodies were published. Herein, we describe a case of anti-MOG antibody-associated demyelinating disease initially diagnosed as typical MS, and, at presentation, not fulfilling the proposed recommendations. This case highlights the expanding spectrum of anti-MOG antibody-associated demyelinating disease, illustrating the distinct and overlapping features of MS and MOG-antibody associated demyelinating disease, providing evidence that on rare occasions these recommendations may prove too restrictive. © 201

Glial fibrillary acidic protein (GFAP)-antibody in children with focal seizures of undetermined cause

Anti-neuronal antibodies that are related with autoimmune encephalitis syndromes may also be found in children with new onset seizures or chronic epilepsy. To unravel the significance of autoimmune astrocytopathy in epilepsy, we investigated serum antibody to glial fibrillary acidic protein (GFAP), another autoantigen described in autoimmune encephalitis with seizures, in 38 children with focal seizures of undetermined cause. GFAP antibody was screened with cell based assay and indirect immunohistochemistry and was found in two boys with normal brain MRI and unrevealing medical history prior to seizures. The 2-year-old boy had chronic treatment-resistant frontal lobe epilepsy. The 2.5-year-old boy had a single episode of focal seizures and remained seizure free thereafter in a follow-up period of 4 years. Nevertheless, he showed severe cognitive and language impairment. These results suggest that autoimmune astrocytopathy may be present in some epilepsy patients. Whether this immune response is a bystander effect generated by seizure-induced astrocytosis or directly involved in epileptogenesis needs to be further studied. © 2020, Belgian Neurological Society